Observational Study With PASCALLERG ® in Patients With Hay Fever

Pascoe Natural Healthcare

Status: Completed

Conditions: Hay Fever

Study type: Observational

Funder types: Industry

Identifiers

NCT01660737

180A12PALL

Details and patient eligibility

About

The aim of this observational study is to document the therapeutic use of PASCALLERG ® for hay fever. Based on the survey is a decrease in disease-specific symptoms when taking PASCALLERG ® over a period of 4 weeks will be documented. In addition to the compatibility can be assessed.

Full description

There are documented male and female patients over the age of one year who suffer from hay fever. The traetment time is about a period of 4 weeks with PASCALLERG® tablets.

Enrollment: 123 patients

Sex: All

Ages: 1+ year old

Volunteers: No Healthy Volunteers

Inclusion criteria

• hay fever

Exclusion criteria

• Lactose intolerance and / or
• Chromium hypersensitivity

Trial design

123 participants in 1 patient group

PASCALLERG® tablets in patients with hay fever

Description:

Patients with lactose intolerance and / or chromium hypersensitivity are excluded from the observational study.